Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07382596 · ClinicalTrials.gov registry record · Phase 4
Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD
A Phase 4 study, sponsored by Dr. Dean Reeves Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT07382596 is a Phase 4 study that is actively recruiting participants, run by Dr. Dean Reeves Clinic. The registered enrollment target is 50 participants.
The verdict
NCT07382596, a Phase 4 study, is actively recruiting participants, sponsored by Dr. Dean Reeves Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with an injection control of normal saline (NS)
Interventions
- DRUG Dextrose 5% in water bilateral injection
- DRUG Normal saline bilateral injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-16 |
| Est. Completion | 2030-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07382596
The ClinicalTrials.gov registry entry for NCT07382596 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Dean Reeves Clinic, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dextrose 5% in water bilateral injection is the first listed.
NCT07382596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07382596 about?
NCT07382596 is a clinical study titled "Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD". PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PT...
What is the current status of trial NCT07382596?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2026-05-16. Estimated completion is 2030-04-01.
What interventions are being tested in trial NCT07382596?
The interventions under investigation include: Dextrose 5% in water bilateral injection (DRUG), Normal saline bilateral injection (DRUG).
Who is sponsoring clinical trial NCT07382596?
This trial is sponsored by Dr. Dean Reeves Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.